Find an Alzheimer's clinical trial

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Search title, drug, condition or sponsor

Recruiting

Exact registry status

Phase

Intervention class

Study type

Country

Results per page

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,201–7,225 of 7,816 matching trials · page 289 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial	Phase	Status	Enrolled	Sponsor	Last updated
Research Study on Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) NCT01114815 Runs in: United States · 1 site	NA other	COMPLETED	100	NYU Langone Health OTHER	2013-01-21
Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers NCT01153607 BAY1006578; BAY1006578; BAY1006578 Runs in: Finland; Sweden · 2 sites	PHASE1 other	COMPLETED	24	Lantheus Biosciences Ltd. INDUSTRY	2013-01-21
Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease NCT00334568 Rosiglitazone XR (extended release) oral tablets; Placebo Runs in: United Kingdom · 1 site	PHASE2 other	TERMINATED	12	GlaxoSmithKline INDUSTRY	2013-01-14
Haloperidol vs. Valproate in Agitation NCT01750541 Haloperidol; Valproate Runs in: Iran · 1 site	PHASE3 other	COMPLETED	56	Shahid Beheshti University of Medical Sciences OTHER	2013-01-08
The Montefiore Metoclopramide Study NCT00475306 metoclopramide 10 mg; Diphenhydramine 25 mg; Placebo; Metoclopramide 20 mg Runs in: United States · 1 site	PHASE4 other	COMPLETED	289	Montefiore Medical Center OTHER	2012-12-31
Efficacy and Safety of Filgrastim in Alzheimer's Disease NCT01617577 G-CSF; filgrastim; Placebo Runs in: United States · 1 site	PHASE1\|PHASE2 other	COMPLETED	8	University of South Florida OTHER	2012-12-27
The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease NCT01054976 Galantamine	PHASE4 symptomatic-cholinergic	COMPLETED	99	Janssen Korea, Ltd., Korea INDUSTRY	2012-12-24
Atomoxetine and Huntington's Disease NCT00368849 atomoxetine; Matching Placebo Runs in: United States · 1 site	PHASE2 other	COMPLETED	20	University of Iowa OTHER	2012-12-20
Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and Actigraphy NCT01384344 observational Runs in: France · 1 site	NA other	COMPLETED	82	Centre Hospitalier Universitaire de Nice OTHER	2012-12-18
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days NCT01547169 Placebo Comparator; insulin detemir; insulin detemir Runs in: United States · 1 site	PHASE2 other	COMPLETED	60	University of Washington OTHER	2012-12-18
Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis NCT00409175 Fx-1006A; Placebo Runs in: Argentina; Brazil; France; Germany; Portugal; Spain; Swed... · 10 sites	PHASE2\|PHASE3 other	COMPLETED	128	Pfizer INDUSTRY	2012-12-17
An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy NCT00791492 Fx-1006A Runs in: Argentina; Brazil; France; Germany; Portugal; Sweden · 11 sites	PHASE2\|PHASE3 other	COMPLETED	86	Pfizer INDUSTRY	2012-12-17
Therapeutic Effect of Direct Current Stimulation on Cognitive Function of Mild to Moderate Alzheimer Patients NCT01746498 Direct current stimulation using Anodal electrode; direct current s... Runs in: Egypt · 1 site	NA other	COMPLETED	33	Assiut University OTHER	2012-12-17
Effect of LY2062430 on the Progression of Alzheimer's Disease NCT00904683 LY2062430; Placebo Runs in: Australia; France; Germany; Italy; Japan; Poland; Russia;... · 95 sites	PHASE3 other	COMPLETED	1,040	Eli Lilly and Company INDUSTRY	2012-12-13
Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease NCT00711204 Donepezil Hydrochloride (Aricept) Runs in: United States · 1 site	PHASE4 symptomatic-cholinergic	WITHDRAWN	0	Eisai Inc. INDUSTRY	2012-12-10
An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease NCT01325402 [18Fluor]AZD4694; [18Fluor]AZD4694; [18Fluor]AZD4694 Runs in: Sweden · 2 sites	PHASE1 other	COMPLETED	16	AstraZeneca INDUSTRY	2012-12-10
AC-1204 Long-term Efficacy Response Trial (ALERT Protocol) NCT01211782 caprylic triglyceride; long-chain triglyceride Runs in: United States · 1 site	PHASE2\|PHASE3 other	WITHDRAWN	0	Cerecin INDUSTRY	2012-12-04
Whole Body Vibration Exercise for Elderly With Cognitive Impairments NCT01734083 Whole body vibration exercise; Conventional exercise Runs in: Hong Kong · 1 site	NA other	UNKNOWN	66	The Hong Kong Polytechnic University OTHER	2012-11-27
Randomized Trial of a Nutritional Supplement in Alzheimer's Disease NCT00678431 Resveratrol with Glucose, and Malate; Placebo Runs in: United States · 1 site	PHASE3 other	COMPLETED	27	US Department of Veterans Affairs OTHER_GOV	2012-11-15
An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease NCT00939783 Dimebon Runs in: Canada; Puerto Rico; United States · 105 sites	PHASE3 other	TERMINATED	649	Pfizer INDUSTRY	2012-11-14
A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration NCT00187525 Memantine	PHASE4 symptomatic-cholinergic	COMPLETED	—	University of California, San Francisco OTHER	2012-11-12
The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients NCT01137799 JNJ-39393406; placebo; JNJ-39393406; JNJ-39393406; JNJ-39393406; JN... Runs in: Germany · 4 sites	PHASE1 other	TERMINATED	47	Janssen Pharmaceutica N.V., Belgium INDUSTRY	2012-11-08
Musical Dual Task Training to Improve Attention Control for Dementia NCT01709188 Musical Dual Task Training; Walking and Talking Runs in: Taiwan · 1 site	NA other	UNKNOWN	30	Chang Gung Memorial Hospital OTHER	2012-11-08
Treatment of Aggressive Behavior and Post-Traumatic Stress Disorder NCT01519193 Narrative Exposure Therapy for violent offenders (NETvo) Runs in: Burundi · 1 site	PHASE2 other	COMPLETED	42	University of Konstanz OTHER	2012-11-07
Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon NCT00907595 Ramelteon; Placebo Runs in: United States · 1 site	NA other	WITHDRAWN	0	Massachusetts General Hospital OTHER	2012-11-06

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry: ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file: 7,816
Source file: trials.csv (3.8 MB, 7816 rows)
Basis: Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024 · score 88/100
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial The Lancet. Neurology, 2026 · score 86/100
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial Lancet (London, England), 2021 · score 86/100
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease Journal of Alzheimer's disease : JAD, 2026 · score 86/100
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial EBioMedicine, 2024 · score 85/100

All 162 studies on Clinical trials →